Pages that link to "Q41248663"

The following pages link to Continuous age- and sex-adjusted reference intervals of urinary markers for cerebral creatine deficiency syndromes: a novel approach to the definition of reference intervals (Q41248663):

Displaying 21 items.

• Creatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case (Q37002978) (← links)
• Newborn screening for Krabbe's disease (Q38957254) (← links)
• Prevalence of Creatine Deficiency Syndromes in Children With Nonsyndromic Autism (Q41036463) (← links)
• Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics (Q47836956) (← links)
• Precision newborn screening for lysosomal disorders. (Q50096104) (← links)
• Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease. (Q52820616) (← links)
• Simultaneous Testing for 6 Lysosomal Storage Disorders and X-Adrenoleukodystrophy in Dried Blood Spots by Tandem Mass Spectrometry (Q87962302) (← links)
• An overview of clinical decision support systems: benefits, risks, and strategies for success (Q89668837) (← links)
• Next-generation reference intervals for pediatric hematology (Q90042756) (← links)
• Reducing False-Positive Results in Newborn Screening Using Machine Learning (Q90452063) (← links)
• Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia: A comparison among participants between 2 and 53 years (Q93171443) (← links)
• Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency (Q94571337) (← links)
• Comparison of four algorithms on establishing continuous reference intervals for pediatric analytes with age-dependent trend (Q96121959) (← links)
• Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia (Q96292157) (← links)
• Laboratory monitoring of patients with hereditary tyrosinemia type I (Q96430764) (← links)
• Hot topics in coagulation testing: Important considerations for testing children for bleeding/thrombotic disorders (Q96434607) (← links)
• A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage Disorders (Q98504007) (← links)
• The Combined Impact of CLIR Post-Analytical Tools and Second Tier Testing on the Performance of Newborn Screening for Disorders of Propionate, Methionine, and Cobalamin Metabolism (Q100728825) (← links)
• Pregnancy-specific continuous reference intervals for haematology parameters from an Australian dataset: A step toward dynamic continuous reference intervals (Q100959824) (← links)
• Treating epilepsy with options other than antiepileptic medications (Q101140195) (← links)
• Development of Strategies to Decrease False Positive Results in Newborn Screening (Q101223352) (← links)